Hengrui has reported topline data from the 301 study of their dual GLP-1 and GIP agonist HRS9531, administered as a ...

By Mariam Sunny (Reuters) -U.S.-based Kailera Therapeutics and Chinese firm Jiangsu Hengrui Pharmaceuticals' experimental weight-loss drug has helped overweight patients lose up to 17.7% of body ...

Folks on GLP-1 drugs can expect to maintain their weight loss if they have a disruption in access, as long as they’ve also ...

A new report from the Michigan Department of Insurance and Financial Services shows that health insurance plans covering ...

Experts have issued a cautionary note that around half a million people using weight loss injections could potentially invalidate their travel insurance this summer. Medications such as Mounjaro and ...

Weight loss drugs have become quite popular in the past years. However, there are a few aspects of the drug that need to be explored more. One such aspect is its effect on postmenopausal women.

WEIGHT loss jabs could boost men’s sex lives, a study suggests. Research found injections like Wegovy and Mounjaro can raise ...

Experts are warning people using weight-loss jabs could be invalidating travel insurance if they fail to declare the ...

Research indicates GLP-1 receptor agonists, like Ozempic, may elevate testosterone levels in men while promoting weight loss.

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone ...

While severe climate-related disasters were linked with decreased access to health care infrastructure, moderate climate-related disasters were linked with increased access and redevelopment. In other ...